SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001824293-22-000059
Filing Date
2022-06-28
Accepted
2022-06-28 16:06:03
Documents
15
Period of Report
2022-06-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ck00018242493-20220627.htm   iXBRL 8-K 31415
5 GRAPHIC ck00018242493-20220627_g1.jpg GRAPHIC 16879
6 GRAPHIC ck00018242493-20220627_g2.jpg GRAPHIC 1656
7 GRAPHIC ck00018242493-20220627_g3.jpg GRAPHIC 95792
  Complete submission text file 0001824293-22-000059.txt   453881

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck00018242493-20220627.xsd EX-101.SCH 1941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck00018242493-20220627_lab.xml EX-101.LAB 25848
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck00018242493-20220627_pre.xml EX-101.PRE 13598
9 EXTRACTED XBRL INSTANCE DOCUMENT ck00018242493-20220627_htm.xml XML 11507
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 221050122
SIC: 2834 Pharmaceutical Preparations